FoxO1: mute for a tuned metabolism?

被引:15
作者
Cheng, Zhiyong [1 ]
机构
[1] Virginia Tech, Dept Human Nutr Foods & Exercise, Fralin Translat Obes Res Ctr, Coll Agr & Life Sci, Blacksburg, VA 24061 USA
关键词
FoxO1; insulin signaling; insulin resistance; glucose; lipid; metabolic homeostasis; HEPATIC GLUCOSE; IN-VIVO; INSULIN; LIVER;
D O I
10.1016/j.tem.2015.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The transcription factor forkhead box O1 (FoxO1) plays pleiotropic roles in insulin-mediated glucose and lipid metabolism. In the liver, glucose production is finely controlled by insulin signaling that dampens FoxO1. Two recent studies show that silencing of FoxO1 is also essential for extra-hepatic insulin signaling to maintain glucose homeostasis.
引用
收藏
页码:402 / 403
页数:2
相关论文
共 10 条
[1]   The AKTion in non-canonical insulin signaling [J].
Cheng, Zhiyong ;
White, Morris F. .
NATURE MEDICINE, 2012, 18 (03) :351-353
[2]   Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models [J].
Cheng, Zhiyong ;
White, Morris F. .
ANTIOXIDANTS & REDOX SIGNALING, 2011, 14 (04) :649-661
[3]   Foxo1 integrates insulin signaling with mitochondrial function in the liver [J].
Cheng, Zhiyong ;
Guo, Shaodong ;
Copps, Kyle ;
Dong, Xiaochen ;
Kollipara, Ramya ;
Rodgers, Joseph T. ;
Depinho, Ronald A. ;
Puigserver, Pere ;
White, Morris F. .
NATURE MEDICINE, 2009, 15 (11) :1307-U105
[4]   A Mutant Allele Encoding DNA Binding-Deficient FoxO1 Differentially Regulates Hepatic Glucose and Lipid Metabolism [J].
Cook, Joshua R. ;
Matsumoto, Michihiro ;
Banks, Alexander S. ;
Kitamura, Tadahiro ;
Tsuchiya, Kyoichiro ;
Accili, Domenico .
DIABETES, 2015, 64 (06) :1951-1965
[5]   Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation [J].
Dong, Xiaocheng C. ;
Copps, Kyle D. ;
Guo, Shaodong ;
Li, Yedan ;
Kollipara, Ramya ;
DePinho, Ronald A. ;
White, Morris F. .
CELL METABOLISM, 2008, 8 (01) :65-76
[6]   Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 [J].
Lu, Mingjian ;
Wan, Min ;
Leavens, Karla F. ;
Chu, Qingwei ;
Monks, Bobby R. ;
Fernandez, Sully ;
Ahima, Rexford S. ;
Ueki, Kohjiro ;
Kahn, C. Ronald ;
Birnbaum, Morris J. .
NATURE MEDICINE, 2012, 18 (03) :388-U254
[7]   Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice [J].
Nagashima, Takeyuki ;
Shigematsu, Nobuharu ;
Maruki, Riyo ;
Urano, Yasuharu ;
Tanaka, Hirotsugu ;
Shimaya, Akiyoshi ;
Shimokawa, Teruhiko ;
Shibasaki, Masayuki .
MOLECULAR PHARMACOLOGY, 2010, 78 (05) :961-970
[8]   FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization [J].
O-Sullivan, Insug ;
Zhang, Wenwei ;
Wasserman, David H. ;
Liew, Chong Wee ;
Liu, Jonathan ;
Paik, Jihye ;
DePinho, Ronald A. ;
Stolz, Donna Beer ;
Kahn, C. Ronald ;
Schwartz, Michael W. ;
Unterman, Terry G. .
NATURE COMMUNICATIONS, 2015, 6
[9]   Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo [J].
Titchenell, Paul M. ;
Chu, Qingwei ;
Monks, Bobby R. ;
Birnbaum, Morris J. .
NATURE COMMUNICATIONS, 2015, 6
[10]   Targeting FoxO1 with AS1842856 Suppresses Adipogenesis [J].
Zou, Peng ;
Liu, Longhua ;
Zheng, Louise ;
Liu, Lu ;
Stoneman, Rebecca E. ;
Cho, Alicia ;
Emery, Ashley ;
Gilbert, Elizabeth R. ;
Cheng, Zhiyong .
CELL CYCLE, 2014, 13 (23) :3759-3767